- Home
- HOOK vs SOHO Comparison
HOOK vs SOHO Comparison
Compare HOOK & SOHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOOK
- SOHO
- Stock Information
- Founded
- HOOK 2011
- SOHO 2004
- Country
- HOOK United States
- SOHO United States
- Employees
- HOOK N/A
- SOHO N/A
- Industry
- HOOK Biotechnology: Pharmaceutical Preparations
- SOHO Real Estate Investment Trusts
- Sector
- HOOK Health Care
- SOHO Real Estate
- Exchange
- HOOK Nasdaq
- SOHO Nasdaq
- Market Cap
- HOOK 9.3M
- SOHO 16.3M
- IPO Year
- HOOK 2019
- SOHO 2004
- Fundamental
- Price
- HOOK $1.47
- SOHO $0.75
- Analyst Decision
- HOOK Buy
- SOHO Hold
- Analyst Count
- HOOK 4
- SOHO 1
- Target Price
- HOOK $10.67
- SOHO $1.50
- AVG Volume (30 Days)
- HOOK 134.3K
- SOHO 16.4K
- Earning Date
- HOOK 05-20-2025
- SOHO 05-13-2025
- Dividend Yield
- HOOK N/A
- SOHO N/A
- EPS Growth
- HOOK N/A
- SOHO N/A
- EPS
- HOOK N/A
- SOHO N/A
- Revenue
- HOOK $43,946,000.00
- SOHO $180,394,287.00
- Revenue This Year
- HOOK N/A
- SOHO $13.93
- Revenue Next Year
- HOOK N/A
- SOHO N/A
- P/E Ratio
- HOOK N/A
- SOHO N/A
- Revenue Growth
- HOOK 118.32
- SOHO 3.91
- 52 Week Low
- HOOK $0.72
- SOHO $0.59
- 52 Week High
- HOOK $10.50
- SOHO $1.54
- Technical
- Relative Strength Index (RSI)
- HOOK 67.61
- SOHO 53.73
- Support Level
- HOOK $1.14
- SOHO $0.70
- Resistance Level
- HOOK $1.67
- SOHO $0.80
- Average True Range (ATR)
- HOOK 0.16
- SOHO 0.05
- MACD
- HOOK 0.10
- SOHO 0.01
- Stochastic Oscillator
- HOOK 78.69
- SOHO 45.90
About HOOK HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc is a clinical-stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. Its oncology portfolio targets oncoviral cancer antigens and next-generation antigens and includes two primary programs in development: eseba-vec (formerly HB-200) and HB-700. Eseba-vec is in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) head and neck cancers. It also develops infectious disease therapies in partnership with other companies. Its Hepatitis B (HBV) program, HB-400, and Human Immunodeficiency Virus (HIV) program, HB-500, are being developed in partnership with Gilead.
About SOHO Sotherly Hotels Inc.
Sotherly Hotels Inc is engaged in Hotel operations. The company is a self-managed and self-administered lodging real estate investment trust that was formed to own, acquire, renovate, and reposition full-service, upscale, and upper-upscale hotel properties located in primary markets in the mid-Atlantic and southern United States. It generates revenue through the rooms, food, beverage, and other services. Geographically, the group has its presence in the regions of Florida, Georgia, Indiana, Maryland, North Carolina, Pennsylvania, Texas, and Virginia.